JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans.
Fourie AM, Cheng X, Chang L, Greving C, Li X, Knight B, Polidori D, Patrick A, Bains T, Steele R, Allen SJ, Patch RJ, Sun C, Somani S, Bhandari A, Liu D, Huie K, Li S, Rodriguez MA, Xue X, Kannan A, Kosoglou T, Sherlock JP, Towne J, Holland MC, Modi NB.
Fourie AM, et al. Among authors: kannan a.
Sci Rep. 2024 Jul 30;14(1):17515. doi: 10.1038/s41598-024-67371-5.
Sci Rep. 2024.
PMID: 39080319
Free PMC article.